Proteomics profiling reveals inflammatory biomarkers of antidepressant treatment response: Findings from the CO-MED trial.
about
Peripheral biomarkers of major depression and antidepressant treatment response: Current knowledge and future outlooks.Accurately identifying patients who are excellent candidates or unsuitable for a medication: a novel approach.Personalized Antidepressant Selection and Pathway to Novel Treatments: Clinical Utility of Targeting Inflammation.
P2860
Proteomics profiling reveals inflammatory biomarkers of antidepressant treatment response: Findings from the CO-MED trial.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Proteomics profiling reveals i ...... indings from the CO-MED trial.
@en
Proteomics profiling reveals i ...... indings from the CO-MED trial.
@nl
type
label
Proteomics profiling reveals i ...... indings from the CO-MED trial.
@en
Proteomics profiling reveals i ...... indings from the CO-MED trial.
@nl
prefLabel
Proteomics profiling reveals i ...... indings from the CO-MED trial.
@en
Proteomics profiling reveals i ...... indings from the CO-MED trial.
@nl
P2093
P2860
P1476
Proteomics profiling reveals i ...... indings from the CO-MED trial.
@en
P2093
Bharathi S Gadad
Bruce D Grannemann
Madhukar H Trivedi
Manish K Jha
Taryn L Mayes
P2860
P356
10.1016/J.JPSYCHIRES.2017.05.012
P577
2017-05-26T00:00:00Z